Client Consultation, Health History & Informed Consent

Client consultation, comprehensive health history intake, contraindication screening, and informed consent are the foundational pillars of safe, effective esthetic practice. Estheticians in Arizona must execute thorough pre-treatment evaluations to prevent adverse chemical reactions, tissue damage, and legal liability.

Client Intake Forms and Health History Assessment

Every professional skin care service must begin with a structured consultation using a comprehensive Client Intake Form. The intake form serves as a legal document detailing the client's health profile, dermatological history, current medications, lifestyle habits, and skin care goals.

Crucial Components of the Health History Intake

• Current Medications: Estheticians must screen for prescription topicals (Retin-A, Tazorac, Differin), systemic antibiotics, blood thinners, and oral isotretinoin (Accutane).
• Medical Conditions and Allergies: Documentation of auto-immune diseases, diabetes, cardiac conditions, epilepsy, latex allergies, nut allergies (common in botanical oils), and aspirin/salicylate sensitivities (relevant for salicylic acid peels).
• Recent Dermatological Procedures: Identifying recent cosmetic procedures such as botulinum toxin injections, dermal fillers, laser resurfacing, chemical peels, or surgical cosmetic procedures.
• Lifestyle Factors: Assessing sun exposure habits, tanning bed use, smoking, occupation, water intake, and daily home skin care routines.

---

Contraindication Screening

A contraindication is any medical condition, skin disorder, or drug therapy that renders a specific esthetic treatment unsafe or requires modification to prevent harm. Estheticians must distinguish between absolute contraindications and relative contraindications.

Critical Skin Care Contraindications

1. Oral Isotretinoin (Accutane): Clients who have taken oral isotretinoin within the preceding 6 to 12 months cannot undergo waxing, microdermabrasion, or chemical exfoliation. Accutane inhibits sebaceous gland function and severely thins the stratum corneum, creating extreme vulnerability to epidermal tearing, scarring, and ulceration.
2. Topical Retinoids: Prescribed retinoids (tretinoin, adapalene) thin the outer epidermal layer. Clients must discontinue topical retinoids for 3 to 5 days prior to facial waxing or chemical peeling to prevent skin lifting.
3. Electrical Modalities: High-frequency, galvanic, microcurrent, and electrical muscle stimulation devices are absolutely contraindicated for clients with cardiac pacemakers, metal surgical implants, active epilepsy, pregnancy, or heart conditions.

---

Skin Analysis and Fitzpatrick Scale Assessment

Accurate skin typing and ethnicity/pigmentation analysis are critical prior to applying active exfoliants or thermal treatments.

Determining Skin Types and Conditions

Estheticians analyze skin using a magnifying lamp (loupe) and Wood's lamp to assess skin type (alipidic dry, oily, combination, normal) and specific skin conditions (dehydration, acne, telangiectasia, hyperpigmentation, loss of elasticity).

The Fitzpatrick Scale and Pigmentation Risk

The Fitzpatrick Scale classifies skin types I through VI based on melanin content and the skin's response to ultraviolet (UV) radiation.

• Fitzpatrick Types I–III: Lighter skin tones that burn easily and tan minimally. Lower risk of post-inflammatory hyperpigmentation (PIH), but higher risk of erythema and actinic damage.
• Fitzpatrick Types IV–VI: Deeper skin tones rich in melanin that tan easily and rarely burn. Highly susceptible to Post-Inflammatory Hyperpigmentation (PIH), keloid scarring, and rebound hyperpigmentation when exposed to aggressive chemical peels, high-heat wax, or improper exfoliation.

---

Patch Testing Protocols

Patch testing is a vital safety protocol used to identify potential allergic contact dermatitis or extreme sensitivities before performing full-face chemical treatments, lash tinting, or applying aggressive active serums.

Step-by-Step Patch Test Procedure

1. Selection Site: Apply a small amount of the targeted product (e.g., lash tint, chemical peel solution, or depilatory wax) to a clean test site, typically behind the ear (post-auricular) or on the inner fold of the elbow (antecubital fossa).
2. Observation Window: Allow the product to remain on the skin for the manufacturer's specified duration, instructing the client to keep the area dry and un-rubbed for 24 to 48 hours.
3. Reaction Evaluation: Examine the site for signs of adverse reaction, including erythema (redness), edema (swelling), pruritus (itching), burning sensations, or vesiculation (blistering). Any positive reaction mandates avoiding the product entirely.

---

Informed Consent and Liability Documentation

An Informed Consent Form is a legal document in which the client acknowledges that they have been informed of the nature of the treatment, expected sensations, potential risks, and post-treatment home care expectations.

Essential Consent Form Requirements

• Detailed description of the service to be performed (e.g., 30% Glycolic Acid Peel).
• Explicit warning of common transient side effects (slight tingling, temporary redness, mild flaking).
• Affirmation by the client that all health history information disclosed on the intake form is accurate and complete.
• Statement of client agreement to follow all recommended post-care guidelines, including daily broad-spectrum SPF sunscreen application.

---

Record Retention and Confidentiality Rules

Maintaining detailed, organized client files is both a legal requirement and an ethical duty under Arizona business and health standards.

• Record Retention Period: Arizona service records, client health intake questionnaires, patch test logs, and signed consent waivers should be retained securely for a minimum of 3 to 5 years.
• Updating Client Notes: Estheticians must update the client's chart at every visit, recording date, specific products used, peel concentrations, skin reactions, and home care recommendations.
• Client Confidentiality: Client personal data and health history records must be stored securely in locked cabinets or encrypted digital databases to protect privacy.